Title Hybrid Imaging Technique (HIT) Guided Biopsy to Map Prostatic Adenocarcinoma in Patients Undergoing Prostatectomy
Contact KKlaes
Principal Investigator Anurag Singh, MD
Study Number 133608
Phase1
Summary The objective of this study is to determine the accuracy of HIT (Hybrid imaging technology) guided biopsies for prostate cancer mapping. Our primary hypothesis is that HIT guided biopsies will accurately localize foci of prostate cancer.
Eligibility
- Patients must have histologically confirmed diagnosis of prostate cancer
- Patients must have elected to undergo radical prostatectomy using an open, laparoscopic or robotic approach
- Patients must be at least 18 years of age and able to provide written informed consent
- No history of radiotherapy, chemotherapy or hormone therapy within 6 months of surgery
- Patients must have no history of rectal or anal disease